Multiple Sclerosis

MD IQ

Conference Coverage

Tocilizumab beat azathioprine for NMOSD

STOCKHOLM – The first-ever head-to-head trial compared the two drugs in highly relapsing neuromyelitis optica spectrum disorder.

Pages